20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
IQVIA Holdings Inc (IQV) operates in the Life Sciences Tools & Services industry and is headquartered in Durham, United States with about 94,000 employees. Its market capitalization is roughly $44 billion. In the fiscal year ended 2025-12-31, IQV reported $16.3B in revenue and $1.4B in net income.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Interactive charts & full statements → Open the IQV valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $17.0B | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B | $11.4B | $11.1B | $10.4B | $9.7B | $6.8B | $5.7B | $5.5B | $5.1B | $4.9B | $4.3B | $3.9B |
| Gross Profit | $4.5B | $4.3B | $5.4B | $5.2B | $5.0B | $4.6B | $3.9B | $3.8B | $3.7B | $3.4B | $2.1B | $1.6B | $1.5B | $1.3B | $1.2B | $1.1B | $1.1B |
| Gross Margin % | 26.2% | 26.3% | 34.9% | 35.0% | 34.9% | 33.5% | 34.0% | 34.2% | 35.2% | 35.0% | 30.3% | 28.3% | 27.5% | 26.2% | 25.3% | 26.4% | 28.5% |
| Operating Income (EBIT) | $2.3B | $2.3B | $2.2B | $2.0B | $1.8B | $1.4B | $731M | $777M | $741M | $719M | $642M | $647M | $590M | $462M | $396M | $345M | $395M |
| Operating Margin % | 13.6% | 14.0% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 7.4% | 9.4% | 11.3% | 10.8% | 9.1% | 8.2% | 8.0% | 10.1% |
| Net Income | $1.4B | $1.4B | $1.4B | $1.4B | $1.1B | $966M | $279M | $191M | $259M | $1.3B | $115M | $387M | $356M | $227M | $178M | $242M | $161M |
| Net Margin % | 8.1% | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.5% | 1.7% | 6.8% | 6.5% | 4.4% | 3.6% | 5.6% | 4.1% |
| EBITDA | $3.5B | $3.5B | $3.5B | $3.3B | $2.9B | $2.8B | $2.1B | $2.0B | $1.9B | $1.7B | $849M | $768M | $723M | $554M | $500M | $386M | $467M |
| Earnings Per Share (EPS) | $8.05 | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.88 | $0.76 | $3.08 | $2.72 | $1.77 | $1.39 | $1.90 | $1.26 |
| Shares Outstanding (M) | 169M | 174M | 183M | 186M | 191M | 195M | 195M | 200M | 208M | 223M | 152M | 126M | 131M | 128M | 128M | 128M | 128M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $4.4B | $4.2B | $4.4B | $4.1B | $4.0B | $3.8B | $4.0B | $3.9B |
| Gross Profit | $1.4B | $1.4B | $292M | $1.4B | $1.3B | $1.3B | $1.4B | $1.4B |
| Gross Margin % | 32.9% | 32.6% | 6.7% | 33.5% | 32.9% | 33.9% | 34.8% | 35.4% |
| Operating Income (EBIT) | $506M | $514M | $732M | $553M | $506M | $496M | $626M | $550M |
| Operating Margin % | 11.6% | 12.4% | 16.8% | 13.5% | 12.6% | 13.0% | 15.8% | 14.1% |
| Net Income | $256M | $274M | $514M | $331M | $266M | $249M | $437M | $285M |
| Net Margin % | 5.9% | 6.6% | 11.8% | 8.1% | 6.6% | 6.5% | 11.0% | 7.3% |
| EBITDA | $790M | $808M | $1.0B | $883M | $781M | $753M | $1.0B | $797M |
| Earnings Per Share (EPS) | $1.52 | $1.61 | $2.99 | $1.93 | $1.54 | $1.40 | $2.42 | $1.55 |
| Shares Outstanding (M) | 169M | 170M | 172M | 172M | 173M | 177M | 181M | 184M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $2.8B | $2.7B | $2.7B | $2.1B | $2.3B | $2.9B | $2.0B | $1.4B | $1.3B | $970M | $860M | $476M | $432M | $397M | $336M | $161M | $378M |
| Capital Expenditures (CapEx) | $792M | $603M | $602M | $649M | $674M | $640M | $616M | $582M | $459M | $369M | $164M | $78M | $83M | $92M | $71M | $76M | $80M |
| Free Cash Flow (FCF) | $2.0B | $2.1B | $2.1B | $1.5B | $1.6B | $2.3B | $1.3B | $835M | $795M | $601M | $696M | $397M | $349M | $305M | $264M | $85M | $298M |
| FCF Margin % | 11.9% | 12.6% | 13.7% | 10.0% | 11.0% | 16.6% | 11.8% | 7.5% | 7.6% | 6.2% | 10.2% | 6.9% | 6.4% | 6.0% | 5.4% | 2.0% | 7.6% |
| Dividends Paid | — | — | — | — | — | $59M | $44M | $11M | $4.1B | $7.2B | $638M | $2.2B | $425M | $2.1B | $568M | $288M | $67M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $558M | $618M | $735M | $908M | $443M | $568M | $885M | $721M |
| Capital Expenditures (CapEx) | $198M | $127M | $174M | $293M | $151M | $142M | $164M | $150M |
| Free Cash Flow (FCF) | $360M | $491M | $561M | $615M | $292M | $426M | $721M | $571M |
| FCF Margin % | 8.2% | 11.8% | 12.9% | 15.0% | 7.3% | 11.1% | 18.2% | 14.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.9B | $29.9B | $26.9B | $26.7B | $25.3B | $24.7B | $24.6B | $23.3B | $22.5B | $22.7B | $21.2B | $3.9B | $3.3B | $3.1B | $2.5B | $2.3B |
| Cash & Cash Equivalents | $1.9B | $2.0B | $1.7B | $1.4B | $1.2B | $1.4B | $1.8B | $837M | $891M | $959M | $1.2B | $977M | $867M | $778M | $568M | $516M |
| Total Liabilities | $23.6B | $23.3B | $20.8B | $20.6B | $19.6B | $18.6B | $18.3B | $17.0B | $15.6B | $14.4B | $12.3B | $4.3B | $4.0B | $3.7B | $3.9B | $3.3B |
| Total Debt (Short + Long-Term) | $16.0B | $15.7B | $14.0B | $13.7B | $12.7B | $12.1B | $12.5B | $11.6B | $11.0B | $10.2B | $7.2B | $2.5B | $2.3B | $2.0B | $2.4B | $2.0B |
| Total Shareholders' Equity | $6.2B | $6.5B | $6.1B | $6.1B | $5.8B | $6.0B | $6.0B | $6.0B | $6.7B | $8.1B | $8.6B | ($336M) | ($704M) | ($667M) | ($1.4B) | ($970M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IQV viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms